Literature DB >> 20404164

Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.

Yael Kuperman1, Orna Issler, Limor Regev, Ifat Musseri, Inbal Navon, Adi Neufeld-Cohen, Shosh Gil, Alon Chen.   

Abstract

In response to physiological or psychological challenges, the brain activates behavioral and neuroendocrine systems linked to both metabolic and emotional outputs designed to adapt to the demand. However, dysregulation of integration of these physiological responses to challenge can have severe psychological and physiological consequences, and inappropriate regulation, disproportional intensity, or chronic or irreversible activation of the stress response is linked to the etiology and pathophysiology of mood and metabolic disorders. Using a transgenic mouse model and lentiviral approach, we demonstrate the involvement of the hypothalamic neuropeptide Urocortin-3, a specific ligand for the type-2 corticotropin-releasing factor receptor, in modulating septal and hypothalamic nuclei responsible for anxiety-like behaviors and metabolic functions, respectively. These results position Urocortin-3 as a neuromodulator linking stress-induced anxiety and energy homeostasis and pave the way toward better understanding of the mechanisms that mediate the reciprocal relationships between stress, mood and metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404164      PMCID: PMC2889556          DOI: 10.1073/pnas.1003969107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.

Authors:  M S Haque; Y Minokoshi; M Hamai; M Iwai; M Horiuchi; T Shimazu
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

2.  NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation.

Authors:  E Shimizu; Y P Tang; C Rampon; J Z Tsien
Journal:  Science       Date:  2000-11-10       Impact factor: 47.728

3.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  A direct projection from the ventromedial nucleus and retrochiasmatic area of the hypothalamus to the medulla and spinal cord of the rat.

Authors:  L W Swanson; H G Kuypers
Journal:  Neurosci Lett       Date:  1980-05-01       Impact factor: 3.046

7.  Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior.

Authors:  Alon Chen; Eric Zorrilla; Sean Smith; David Rousso; Coree Levy; Joan Vaughan; Cindy Donaldson; Amanda Roberts; Kuo-Fen Lee; Wylie Vale
Journal:  J Neurosci       Date:  2006-05-17       Impact factor: 6.167

Review 8.  Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.

Authors:  Kitt F Petersen; Gerald I Shulman
Journal:  Am J Cardiol       Date:  2002-09-05       Impact factor: 2.778

Review 9.  Stress mechanisms and metabolic complications.

Authors:  I Kyrou; C Tsigos
Journal:  Horm Metab Res       Date:  2007-06       Impact factor: 2.936

10.  Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study.

Authors:  Douglas Carroll; Anna C Phillips; G Neil Thomas; Catharine R Gale; Ian Deary; G David Batty
Journal:  Biol Psychiatry       Date:  2009-04-02       Impact factor: 13.382

View more
  34 in total

1.  Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Authors:  William J Giardino; Gregory P Mark; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.

Authors:  Hongxia Chao; Michael Digruccio; Peilin Chen; Chien Li
Journal:  Endocrinology       Date:  2011-11-08       Impact factor: 4.736

Review 3.  Brown and Beige Adipose Tissues in Health and Disease.

Authors:  Liangyou Rui
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

4.  Mitochondrial DNA polymerase editing mutation, PolgD257A, disturbs stem-progenitor cell cycling in the small intestine and restricts excess fat absorption.

Authors:  Raymond G Fox; Scott Magness; Gregory C Kujoth; Tomas A Prolla; Nobuyo Maeda
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-16       Impact factor: 4.052

5.  Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.

Authors:  W J Giardino; R Pastor; A M J Anacker; E Spangler; D M Cote; J Li; M P Stenzel-Poore; T J Phillips; A E Ryabinin
Journal:  Genes Brain Behav       Date:  2010-09-30       Impact factor: 3.449

6.  Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain.

Authors:  Peilin Chen; David Lin; Jessica Giesler; Chien Li
Journal:  J Comp Neurol       Date:  2011-07-01       Impact factor: 3.215

7.  MicroRNA-19b associates with Ago2 in the amygdala following chronic stress and regulates the adrenergic receptor beta 1.

Authors:  Naama Volk; Evan D Paul; Sharon Haramati; Chen Eitan; Brandon K K Fields; Raaya Zwang; Shosh Gil; Christopher A Lowry; Alon Chen
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

8.  Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor.

Authors:  Kuntal Pal; Kunchithapadam Swaminathan; H Eric Xu; Augen A Pioszak
Journal:  J Biol Chem       Date:  2010-10-21       Impact factor: 5.157

9.  MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34.

Authors:  Sharon Haramati; Inbal Navon; Orna Issler; Gili Ezra-Nevo; Shosh Gil; Raaya Zwang; Eran Hornstein; Alon Chen
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

Review 10.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.